Ricin Vaccine and Methods of Making Thereof
AssigneeThe United States of America as represented by the Secretary of the Army
InventorsPatricia M. Legler, Jaimee R. Compton, Charles B. Millard, Mark A. Olson
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe United States of America as represented by the Secretary of the Army
InventorsPatricia M. Legler, Jaimee R. Compton, Charles B. Millard, Mark A. Olson
Estimating the term…
Disclosed herein ricin toxin A chain polypeptides having an engineered disulfide bond ((SS)RTA) and compositions thereof. The disclosed (SS)RTA polypeptides retain the immunological epitope of wild type RTA, lack detectable N-glycosidase activity or exhibit reduced N-glycosidase activity as compared to controls, and exhibit increased solubility, thermal stability and a lower tendency to self-aggregate as compared to RTA 198 and/or RTA 1-33/44-198. Also disclosed are immunogenic compositions that may be used to immunize a subject against ricin intoxication. Methods of immunizing against, treating, inhibiting, reducing and/and preventing ricin intoxication are disclosed.
An isolated polypeptide comprising, consisting essentially of, or consisting of an amino acid molecule which contains a first sequence that has at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to
An isolated polypeptide comprising, consisting essentially of, or consisting of an amino acid molecule which contains a first sequence that has at least 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100% sequence identity to
18-20. (canceled)
Dependencies are inferred from the claim text.